Correlation Between Kalvista Pharmaceuticals and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and Aerovate Therapeutics, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and Aerovate Therapeutics.
Diversification Opportunities for Kalvista Pharmaceuticals and Aerovate Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Kalvista and Aerovate is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Kalvista Pharmaceuticals and Aerovate Therapeutics
Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 2.09 times more return on investment than Aerovate Therapeutics. However, Kalvista Pharmaceuticals is 2.09 times more volatile than Aerovate Therapeutics. It trades about 0.33 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 877.00 in Kalvista Pharmaceuticals on November 30, 2024 and sell it today you would earn a total of 209.00 from holding Kalvista Pharmaceuticals or generate 23.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Kalvista Pharmaceuticals vs. Aerovate Therapeutics
Performance |
Timeline |
Kalvista Pharmaceuticals |
Aerovate Therapeutics |
Kalvista Pharmaceuticals and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kalvista Pharmaceuticals and Aerovate Therapeutics
The main advantage of trading using opposite Kalvista Pharmaceuticals and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.Kalvista Pharmaceuticals vs. Crinetics Pharmaceuticals | ||
Kalvista Pharmaceuticals vs. Kura Oncology | ||
Kalvista Pharmaceuticals vs. Viridian Therapeutics | ||
Kalvista Pharmaceuticals vs. Replimune Group |
Aerovate Therapeutics vs. Adagene | ||
Aerovate Therapeutics vs. Acrivon Therapeutics, Common | ||
Aerovate Therapeutics vs. Rezolute | ||
Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |